JPRN-jRCT1080222006未知4 期
Effect of lysozyme on exacerbation of chronic obstructive pulmonary disease : a randomised placebo-controlled study
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator)
入排标准
- 年龄范围
- >= 20age old 至 <= 84age old（—）
- 性别
- All
入选标准
- •Patients were eligible for inclusion in the study if they had a smoking history, a diagnosis of COPD, %FEV1< 80% and a ratio of FEV1 to forced vital capacity(FVC) of < 70%, and a documented history of at least one exacerbation leading to any treatment within the previous year.
排除标准
- •Patients with egg allergy
- •Patients with domiciliary oxygen therapy
- •Patients with pneumonia or pulmonary tuberculosis
- •Patients with severe cardiovascular disorder, severe kidney disorder, severe hepatic disorder, severe hematological disorder
- •Patients with cancer
研究者
相似试验
未知
4 期
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum SymptomChronic Obstructive Pulmonary Disease (COPD) and AsthmaJPRN-jRCT1080222009Eisai Co., Ltd.48
已完成
4 期
Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum SymptomAsthmaChronic Obstructive Pulmonary DiseaseNCT01715493Eisai Co., Ltd.48
已完成
4 期
Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled StudyCOPDNCT01645800Eisai Co., Ltd.408
已完成
不适用
The effect of Lansoprazole in the prevention of osteonecrosis of the femoral head in patients with immune diseases treated corticosteroidJPRN-UMIN000018838Sapporo Medical University hospital70
已完成
不适用
The effect of Lansoprazole in the prevention of osteonecrosis of the femoral head in patients with immune diseases treated corticosteroidnon-traumatic osteonecrosis of the femoral headJPRN-UMIN000017648Sapporo Medical University hospital30